| Strategies to target ADAM17 in disease: from its discovery to the iRhom revolution M Calligaris, D Cuffaro, S Bonelli, DP Spanò, A Rossello, E Nuti, ... Molecules 26 (4), 944, 2021 | 80 | 2021 |
| Quantitative proteomics reveals changes induced by TIMP-3 on cell membrane composition and novel metalloprotease substrates AP Carreca, VM Pravatà, D D’Apolito, S Bonelli, M Calligaris, E Monaca, ... International journal of molecular sciences 22 (5), 2392, 2021 | 7 | 2021 |
| High-resolution secretome analysis of chemical hypoxia treated cells identifies putative biomarkers of chondrosarcoma DP Spanò, S Bonelli, M Calligaris, AP Carreca, C Carcione, G Zito, ... Proteomes 10 (3), 25, 2022 | 6 | 2022 |
| Proof-of-Concept Study on the Use of Tangerine-Derived Nanovesicles as siRNA Delivery Vehicles toward Colorectal Cancer Cell Line SW480 N Rabienezhad Ganji, O Urzì, V Tinnirello, E Costanzo, G Polito, ... International Journal of Molecular Sciences 25 (1), 546, 2023 | 4 | 2023 |
| Identification of membrane proteins regulated by ADAM15 by SUSPECS proteomics M Calligaris, CY Yang, S Bonelli, DP Spanò, SA Müller, SF Lichtenthaler, ... Frontiers in Molecular Biosciences 10, 1162504, 2023 | 3 | 2023 |
| An In Vitro Model of Glioma Development G Schiera, P Cancemi, CM Di Liegro, F Naselli, S Volpes, I Cruciata, ... Genes 14 (5), 990, 2023 | 2 | 2023 |
| Quantitative proteomics reveals that ADAM15 can have proteolytic-independent functions in the steady state CY Yang, S Bonelli, M Calligaris, AP Carreca, SA Müller, SF Lichtenthaler, ... Membranes 12 (6), 578, 2022 | 2 | 2022 |
| iRhom2 regulates ectodomain shedding and surface expression of the major histocompatibility complex (MHC) class I M Calligaris, DP Spanò, S Bonelli, SA Müller, C Carcione, D D’apolito, ... Cellular and Molecular Life Sciences 81 (1), 163, 2024 | | 2024 |
| Proteomic analysis and functional validation reveal distinct therapeutic capabilities related to priming of mesenchymal stromal/stem cells with IFN-γ and hypoxia: potential … M Calligaris, G Zito, R Busà, M Bulati, G Iannolo, A Gallo, AP Carreca, ... Frontiers in Cell and Developmental Biology 12, 1385712, 2024 | | 2024 |
| Development of a proteomic workflow for the identification of heparan sulfate proteoglycan-binding substrates of ADAM17 M Calligaris, D Spanò, S Mueller, S Bonelli, ML Pinto, G Zito, C Blobel, ... | | 2024 |
| A disintegrin and metalloproteinases (ADAMs) and tumor necrosis factor-alpha-converting enzyme (TACE) D Cuffaro, SD Scilabra, DP Spanò, M Calligaris, E Nuti, A Rossello Metalloenzymes, 207-237, 2024 | | 2024 |
| In vitro model of liver ischemia/reperfusion injury identifies iRhom2 as new target of disease G Zito, M Calligaris, V Miceli, C Carcione, C Gatto, S Scilabra, D Pagano, ... Journal of Hepatology 78, S457, 2023 | | 2023 |
| Use of integrated proteomic approaches to identify novel functions of iRhom2. M CALLIGARIS | | 2023 |
| Mesenchymal Stem/Stromal Cells: HIGH-RESOLUTION MASS-SPECTROMETRY-BASED PROTEOMICS AND FUNCTIONAL VALIDATION REVEALED DISTINCT THERAPEUTIC CAPABILITIES RELATED TO DIFFERENT … V Miceli, SD Scilabra, M Calligaris, G Zito, R Busà, A Gallo, M Bulati, ... Cytotherapy 25 (6), S73-S74, 2023 | | 2023 |
| An innovative proteomic workflow identifies ECM-binding ADAM17 substrates SD Scilabra, M Calligaris, SA Mueller, SF Lichtenthaler INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY 101 (3-4), A5-A5, 2020 | | 2020 |
